At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Hemorrhoidopexydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEA™ Hemorrhoid And Prolapse Stapling Set With DST Series™ Technology Im A Hemorrhoidopexy Procedure
In Brief
A clinical study evaluating Hemorrhoidopexy for Hemorrhoid. Completed, enrolled 27 participants across 1 site.
Detailed Summary
Trial Objectives The primary objectives of this clinical trial are to estimate the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set: overall performance defined by the successful creation of a normal staple line safety as measured by the 30 day incidence of adverse events.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhoid
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedJul 2010
Primary CompletionMar 2011
Study CompletionJul 2011
TodayJul 2026
First PostedJul 26, 2010
Enrollment StartJul 1, 2010
Primary CompletionMar 1, 2011
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.9 years ago
Interventions
Hemorrhoidopexydevice